Cargando…

20例多中心型Castleman病患者的临床特征及预后分析

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295610/
https://www.ncbi.nlm.nih.gov/pubmed/34384159
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.012
_version_ 1783725465642467328
collection PubMed
description
format Online
Article
Text
id pubmed-8295610
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-82956102021-08-23 20例多中心型Castleman病患者的临床特征及预后分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2021-06 /pmc/articles/PMC8295610/ /pubmed/34384159 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.012 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 短篇论著
20例多中心型Castleman病患者的临床特征及预后分析
title 20例多中心型Castleman病患者的临床特征及预后分析
title_full 20例多中心型Castleman病患者的临床特征及预后分析
title_fullStr 20例多中心型Castleman病患者的临床特征及预后分析
title_full_unstemmed 20例多中心型Castleman病患者的临床特征及预后分析
title_short 20例多中心型Castleman病患者的临床特征及预后分析
title_sort 20例多中心型castleman病患者的临床特征及预后分析
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295610/
https://www.ncbi.nlm.nih.gov/pubmed/34384159
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.012
work_keys_str_mv AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī
AT 20lìduōzhōngxīnxíngcastlemanbìnghuànzhědelínchuángtèzhēngjíyùhòufēnxī